Cardiac Injury in Patients With Influenza
NCT03339180 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 466
Last updated 2022-09-21
Summary
This study investigate the prevalence of elevated biomarkers of cardiac injury in patients with suspected influenza infection and the prognostic implication on the composite endpoint of death of any cause, hospitalization due to myocardial infarction, unstable angina, heart failure and stroke.
Conditions
- Influenza, Human
- Myocardial Injury
Sponsors & Collaborators
-
Örebro University, Sweden
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2022-04-30
- Completion
- 2023-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
NCT02565277 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
NCT06336317 ·Status: RECRUITING ·Phase: PHASE4
-
Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection
NCT06401720 ·Status: ENROLLING_BY_INVITATION
-
T-cell Response-Flu Risk in Older Adults
NCT00138398 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases
NCT00607217 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases
NCT00607178 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Proteomic Profiling for Influenza
NCT00133588 ·Status: COMPLETED ·Phase: PHASE4
-
Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?
NCT02263027 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
NCT01945268 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
NCT01032395 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Immune Responses to Influenza Vaccination
NCT03346772 ·Status: RECRUITING ·Phase: PHASE4
-
Training Study to Characterize Biomarkers to Flu Vaccines
NCT01771367 ·Status: COMPLETED ·Phase: NA
-
Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study
NCT00371098 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
NCT03743688 ·Status: COMPLETED
-
Surveillance for Adverse Events Following Influenza Immunization
NCT01318876 ·Status: COMPLETED
-
Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes
NCT03654937 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults
NCT03160118 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza in People With Normal and Weakened Immune Systems
NCT00533182 ·Status: COMPLETED
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
NCT00938392 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Responses Induced by Different Licensed Influenza Vaccines
NCT00902278 ·Status: COMPLETED ·Phase: NA
-
Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™
NCT00377611 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Responses in Health Care Personnel
NCT03323112 ·Status: RECRUITING
-
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 ·Status: TERMINATED ·Phase: PHASE4
-
Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years
NCT00929331 ·Status: COMPLETED ·Phase: PHASE3